FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Obstetrics and Gynaecology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,519)
Research Grants
(12)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Germline variants of homology-directed repair or mismatch repair genes in cervical cancer ()
Kokemüller L, Ramachandran D, Schürmann P, Geffers R, Jentschke M, Böhmer G, Strauß HG, et al.
Journal article
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance ()
Branz A, Matek C, Lange F, Bahlinger V, Klümper N, Hölzel M, Strissel P, et al.
Journal article
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025)
Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al.
Journal article
Correction to: Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (BMC Medicine, (2024), 22, 1, (346), 10.1186/s12916-024-03548-z) (2025)
Liwinski T, Auer MK, Schröder J, Pieknik I, Casar C, Schwinge D, Henze L, et al.
Journal article, Erratum
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis (2025)
Fu Z, Borho L, Taylor SE, Kelemen LE, DeFazio A, Webb PM, Köbel M, et al.
Journal article
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025)
Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al.
Journal article
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study (2025)
Decker T, Brucker C, Engel A, Fasching P, Göhler T, Jackisch C, Janssen J, et al.
Journal article
Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer (2025)
Hirschmann M, Schnellhardt S, Rübner M, Segelhorst S, Ott O, Erber R, Daniel C, et al.
Journal article
Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer (2025)
Lüftner D, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, et al.
Journal article, Review article
Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer (2025)
Janni W, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, et al.
Journal article, Review article
‹
1
2
3
...
152
›